This information was published on 2024-12-17T07:39:45 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2506347 (IR 1827321) |
| (220) |
05 Jun 2024
|
| (300) |
US, 29 Jan 2024, 98381209
|
| (511) (510) |
Class 5
Pharmaceutical preparations for the prevention of heart and chest conditions, diseases, and disorders; pharmaceutical products for the prevention of cardiothoracic conditions, diseases, and disorders; pharmaceutical preparations for preventing disease progression; pharmaceutical preparations for protecting against organ damage; pharmaceutical preparations for protecting against organ damage following organ transplant; pharmaceutical preparations for lowering the risks associated with cardiac surgery; pharmaceutical preparations for lowering the risks associated with cardiac surgery, namely, pharmaceutical preparations for aortic aneurysm, atrial fibrillation, left ventricular assist devices, and transcatheter aortic valve replacement. |
| (540) | CYAXXVI |
| (550) | Word |
| (730) |
Renibus Therapeutics, Inc.
|
Find out more about publications on the About page.